Amendment No. 6 to Schedule 13D for MediWound Ltd.

This Amendment No. 6 to Schedule 13D is filed by Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, Clal Industries Ltd., Clal Biotechnology Industries Ltd., Clal Life Sciences L.P., and Len Blavatnik (collectively, the 'Reporting Persons') in respect of MediWound Ltd. The amendment updates the ownership details of the Reporting Persons in the Ordinary Shares of MediWound Ltd. As of September 30, 2025, the Reporting Persons collectively own 11.56% of the Ordinary Shares, with Clal Biotechnology Industries Ltd. directly owning 308,811 shares and sharing voting and investment power over 1,172,710 shares owned by Clal Life Sciences L.P. The amendment is filed in accordance with Rule 13d-2 of the Securities Exchange Act of 1934, as amended, and reflects material changes since the last filing.